Authors: Palamanda, Jairam R.; Kumari, Pramila; Murgolo, Nicholas; Benbow, Larry; Lin, Xinjie; Nomeir, Amin A.

Source: Drug Metabolism Letters, Volume 3, Number 3, August 2009 , pp. 171-175(5)

Publisher: Bentham Science Publishers

Abstract:

Cytochrome P450 (CYP) induction in rodents and humans is considered a liability for new chemical entities (NCEs) in drug discovery. In particular, CYP1A1 and CYP2B1/2 have been associated with the induction of liver tumors in oncogenicity studies during safety evaluation studies of potential drugs. In our laboratory, real time PCR (Taqman®) has been used to quantify the induction of rat hepatic CYP1A1 and CYP2B1/2 in precision-cut rat liver slices. A novel technology that does not require m-RNA isolation or RT-PCR, (developed by NanoString Technologies®) has been investigated to quantify CYP1A1 and CYP2B1/2 induction in rat liver slices. Seventeen commercially available compounds were evaluated using both Taqman® and NanoString® technologies. Precision-cut rat liver slices were incubated with individual compounds for 24 hr at 37°C in a humidified CO2 incubator and CYP1A1 and CYP2B1/2 m-RNA molecules were quantified. The results from the NanoString® technology were similar to those of the Taqman® with a high degree of correlation for both CYP isoforms (r2>0.85). Therefore, NanoString provides an additional new technology to evaluate the induction of CYP1A1 and 2B1/2, as well as potentially other enzymes or transporters in rat liver slices.

Keywords: NanoString®; Automation; HTP or High Throughput; Liver Slices; Real Time PCR; Cytochrome P450; Induction; CYP1A1; CYP2B1/2

Document Type: Research article

DOI: http://dx.doi.org/10.2174/187231209789352094

Publication date: 2009-08-01

More about this publication?

• Drug Metabolism Letters publishes short papers on major advances in all areas of drug metabolism and disposition. The emphasis will be on publishing quality papers very rapidly. Letters will be processed rapidly by taking full advantage of the Internet technology for both the submission and review of manuscripts. The journal covers the following areas:
  
  In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites, reactive intermediate and glutathione conjugates.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Palamanda, Jairam R. ;  Kumari, Pramila ;  Murgolo, Nicholas ;  Benbow, Larry ;  Lin, Xinjie ;  Nomeir, Amin A.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers